About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Menstrual Differences in Airway Inflammation in Asthma

NCT00584441·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

The University of Texas Medical Branch, Galveston

Age

18–50

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

With diagnosis of Asthma (ICD-9 Code 493)
Requiring low to moderate dose inhaled corticosteroids for control.
With Pre-bronchodilator FEV1 ≥50% and ≤90% of predicted normal
With a positive bronchodilator response
Non smoker or Ex-smoker (Quit \>1 year ago)
Regular menstrual cycle (24-35 days cycle)
With and without OCP use
Constant dose of asthma maintenance medication for at least 30 days prior to enrolment

You may not be if

Recent use of systemic steroids (\<30 days)
Severe Asthma (FEV1 \<50% or frequent exacerbations or systemic steroid dependence)
Negative bronchodilator response
Current Smoker
Irregular Menses or postmenopausal
Positive pregnancy test
Use of hormonal contraceptives other than monophasic OCPs
Exacerbation or Respiratory Infection or antibiotic use within the last 30 days

The record

StatusCompleted

PhaseNo phase

Taking part6

StartedSep 2007

UpdatedFeb 13, 2013

Conditions

Where1

University of Texas Medical Branch
Galveston, Texas, United States

Clareo Health | Menstrual Differences in Airway Inflammation in Asthma